FDA clears sepsis test that significantly reduces life-or-death diagnosis time

Sepsis, a life-threatening organ dysfunction, is responsible for an estimated 1 in 5 deaths globally and 1 in 3 deaths that occur within a U.S. hospital. It happens due to a dysregulated immune response to infection, and its high mortality rate correlates to the difficulty in quickly diagnosing and appropriately addressing the origin of infection, be it bacterial, viral, or some other pathogen. Current methods can delay that life-or-death determination for as long as three days.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup